Cargando…

Use of non-contrast Myocardial T1 times to distinguish between fibrosis and normal myocardial tissue, a possible alternative for patients who cannot receive gadolinium-based contrast agents

Detalles Bibliográficos
Autores principales: Addetia, Karima, Singh, Amita, Kawaji, Keigo, Mor-Avi, Victor, Lang, Roberto, Patel, Amit R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032731/
http://dx.doi.org/10.1186/1532-429X-18-S1-P317
_version_ 1782455051811291136
author Addetia, Karima
Singh, Amita
Kawaji, Keigo
Mor-Avi, Victor
Lang, Roberto
Patel, Amit R
author_facet Addetia, Karima
Singh, Amita
Kawaji, Keigo
Mor-Avi, Victor
Lang, Roberto
Patel, Amit R
author_sort Addetia, Karima
collection PubMed
description
format Online
Article
Text
id pubmed-5032731
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50327312016-09-29 Use of non-contrast Myocardial T1 times to distinguish between fibrosis and normal myocardial tissue, a possible alternative for patients who cannot receive gadolinium-based contrast agents Addetia, Karima Singh, Amita Kawaji, Keigo Mor-Avi, Victor Lang, Roberto Patel, Amit R J Cardiovasc Magn Reson Poster Presentation BioMed Central 2016-01-27 /pmc/articles/PMC5032731/ http://dx.doi.org/10.1186/1532-429X-18-S1-P317 Text en © Addetia et al. 2016 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Addetia, Karima
Singh, Amita
Kawaji, Keigo
Mor-Avi, Victor
Lang, Roberto
Patel, Amit R
Use of non-contrast Myocardial T1 times to distinguish between fibrosis and normal myocardial tissue, a possible alternative for patients who cannot receive gadolinium-based contrast agents
title Use of non-contrast Myocardial T1 times to distinguish between fibrosis and normal myocardial tissue, a possible alternative for patients who cannot receive gadolinium-based contrast agents
title_full Use of non-contrast Myocardial T1 times to distinguish between fibrosis and normal myocardial tissue, a possible alternative for patients who cannot receive gadolinium-based contrast agents
title_fullStr Use of non-contrast Myocardial T1 times to distinguish between fibrosis and normal myocardial tissue, a possible alternative for patients who cannot receive gadolinium-based contrast agents
title_full_unstemmed Use of non-contrast Myocardial T1 times to distinguish between fibrosis and normal myocardial tissue, a possible alternative for patients who cannot receive gadolinium-based contrast agents
title_short Use of non-contrast Myocardial T1 times to distinguish between fibrosis and normal myocardial tissue, a possible alternative for patients who cannot receive gadolinium-based contrast agents
title_sort use of non-contrast myocardial t1 times to distinguish between fibrosis and normal myocardial tissue, a possible alternative for patients who cannot receive gadolinium-based contrast agents
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032731/
http://dx.doi.org/10.1186/1532-429X-18-S1-P317
work_keys_str_mv AT addetiakarima useofnoncontrastmyocardialt1timestodistinguishbetweenfibrosisandnormalmyocardialtissueapossiblealternativeforpatientswhocannotreceivegadoliniumbasedcontrastagents
AT singhamita useofnoncontrastmyocardialt1timestodistinguishbetweenfibrosisandnormalmyocardialtissueapossiblealternativeforpatientswhocannotreceivegadoliniumbasedcontrastagents
AT kawajikeigo useofnoncontrastmyocardialt1timestodistinguishbetweenfibrosisandnormalmyocardialtissueapossiblealternativeforpatientswhocannotreceivegadoliniumbasedcontrastagents
AT moravivictor useofnoncontrastmyocardialt1timestodistinguishbetweenfibrosisandnormalmyocardialtissueapossiblealternativeforpatientswhocannotreceivegadoliniumbasedcontrastagents
AT langroberto useofnoncontrastmyocardialt1timestodistinguishbetweenfibrosisandnormalmyocardialtissueapossiblealternativeforpatientswhocannotreceivegadoliniumbasedcontrastagents
AT patelamitr useofnoncontrastmyocardialt1timestodistinguishbetweenfibrosisandnormalmyocardialtissueapossiblealternativeforpatientswhocannotreceivegadoliniumbasedcontrastagents